Bariatric Surgery
Clinician's Perspective: • Hypertension (High Blood Pressure) is often present in persons with obesity. Effective weight management in the form of Bariatric Surgery may lead to improved Blood Pressure control. • In a randomized controlled trial looking into how Roux en Y gastric bypass affects High Blood Pressure management, at
Understanding Obesity
Clinician's Perspective: • Obstructive Sleep Apnea (OSA) is common amongst people with Obesity, however, OSA frequently occurs in non-obese individuals as well. • OSA is primarily driven by how the anatomy or shape of one's upper airway impairs air flow into the lungs. • Bariatric Surgery (weight-loss surgery) significantly
Bariatric Surgery
Clinician's Perspective: • Hydration: Maintaining a daily fluid intake of at least 1 to 1.5 liters is important to prevent kidney complications and reduce symptoms of nausea and tiredness. • Protein: Consuming 60 to 100 grams of protein daily is mandatory to reduce the loss of muscle mass, which
Bariatric Surgery
Clinician's Perspective: • Mortality rates for bariatric procedures are statistically low, generally observed at less than 0.3% (approximately 3 in 1,000 patients) within the first 30 days. • Early Complications: Immediate post-surgical risks include Venous Thromboembolism (blood clots in the veins) and Anastomotic Leaks (leakage at the surgical
Understanding Obesity
Clinician's Perspective: • Insulin Resistance: 95% of patients with obesity and PCOS exhibit Insulin Resistance (a condition where cells fail to respond effectively to insulin), compared to 75% in lean patients. • Visceral Adiposity: Excessive internal belly fat is identified as the primary driver of metabolic dysfunction because it contains
Bariatric Surgery
Clinician's Perspective: • Data indicates that five years after reaching their nadir (lowest weight point), 50.2% of Roux-en-Y gastric bypass patients regain a modest amount of weight, around 15% of the weight they initially lost. • The GLP-1 Deficit: While bariatric surgery successfully restores the postprandial (after-meal) spike of
Bariatric Surgery
Clinician's Perspective: • Dumping Syndrome (DS) manifests in two distinct windows: Early (within 60 minutes) involving rapid fluid shifts and cardiovascular strain, and Late (1–3 hours) characterized by Reactive Postprandial Hypoglycemia (dangerously low blood sugar following a meal). • Surgical Prevalence: While bariatric surgery is highly effective for weight
Bariatric Surgery
Clinician's Perspective: • Eligibility Thresholds: In Asia, bariatric surgery is indicated for individuals with Class III obesity, defined as a Body Mass Index (BMI) of 37.5 or higher, or a BMI of 32.5 when accompanied by at least one obesity-related health condition. In patients with Type 2
Bariatric Surgery
Clinician's Perspective: • Dual Mechanism: The procedure functions through both Gastric Restriction (limiting the stomach's intake capacity) and Intestinal Malabsorption (reducing the surface area available for nutrient uptake). • Hormonal Modulation: Post-operative weight loss is significantly driven by increases in GLP-1 (glucagon-like peptide-1) and PYY (peptide YY), hormones
Bariatric Surgery
Clinician's Perspective: • Mechanical Restriction: The procedure involves the surgical removal of approximately 80% of the stomach, leaving a narrow, tubular "sleeve" about the size of a banana. • Hormonal Modulation: Beyond physical size, the surgery significantly reduces the production of hunger-regulating hormones, which helps suppress appetite and
Bariatric Surgery
Clinician's Perspective: • Superior Weight Maintenance: In the per-protocol analysis (only including patients who kept their original surgical anatomy), Roux-en-Y Gastric Bypass (RYGB) achieved a 65.9% excess body mass index loss compared to 56.1% for Sleeve Gastrectomy (SG) after 10 years. • High Conversion Rates: Nearly 30% of
Bariatric Surgery
Clinician's Perspective: • Reduced Mortality: Metabolic-bariatric surgery was associated with a 49% reduction in all-cause mortality (the risk of death from any cause) compared to traditional non-surgical weight management. • Diabetes Advantage: Participants with Type 2 Diabetes saw the most significant gains, with a 59% reduction in the risk of